Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18007568 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Condition: Anxiety Disorders
Intervention: Drug: risperidone oral tablets

Indicates status has not been verified in more than two years